Scienture Holdings, Inc.
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. Th… Read more
Scienture Holdings, Inc. (SCNX) - Net Assets
Latest net assets as of September 2025: $82.67 Million USD
Based on the latest financial reports, Scienture Holdings, Inc. (SCNX) has net assets worth $82.67 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($104.83 Million) and total liabilities ($22.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $82.67 Million |
| % of Total Assets | 78.86% |
| Annual Growth Rate | 64.95% |
| 5-Year Change | 811.06% |
| 10-Year Change | 29513.14% |
| Growth Volatility | 4354.08 |
Scienture Holdings, Inc. - Net Assets Trend (2006–2024)
This chart illustrates how Scienture Holdings, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Scienture Holdings, Inc. (2006–2024)
The table below shows the annual net assets of Scienture Holdings, Inc. from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $79.07 Million | +14479.46% |
| 2023-12-31 | $542.35K | +58.18% |
| 2022-12-31 | $342.87K | -90.91% |
| 2021-12-31 | $3.77 Million | -56.56% |
| 2020-12-31 | $8.68 Million | +109.63% |
| 2019-12-31 | $4.14 Million | +390.16% |
| 2018-12-31 | $844.67K | +370.79% |
| 2017-12-31 | $-311.93K | +72.83% |
| 2016-12-31 | $-1.15 Million | -529.96% |
| 2015-12-31 | $267.02K | -60.05% |
| 2014-12-31 | $668.44K | +410.79% |
| 2013-12-31 | $130.87K | +100.27% |
| 2008-12-31 | $-48.01 Million | -259231.28% |
| 2007-12-31 | $-18.51K | -291.39% |
| 2006-12-31 | $9.67K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Scienture Holdings, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3902954600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $87.00 | 0.00% |
| Other Components | $118.11 Million | 149.37% |
| Total Equity | $79.07 Million | 100.00% |
Scienture Holdings, Inc. Competitors by Market Cap
The table below lists competitors of Scienture Holdings, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Australian Vintage Ltd
PINK:AUVGF
|
$16.12 Million |
|
Yuan Jen Enterprises Co Ltd
TW:1725
|
$16.12 Million |
|
NSE S.A. EO 155
F:7YM
|
$16.12 Million |
|
Baird Medical Investment Holdings Limited
NASDAQ:BDMD
|
$16.14 Million |
|
Renalytix AI
NASDAQ:RNLX
|
$16.11 Million |
|
Archer Entertainment Media Communications Inc.
PINK:CBLO
|
$16.10 Million |
|
Central Motek Co Ltd
KO:308170
|
$16.10 Million |
|
MARKEL CORP (MKV.SG)
STU:MKV
|
$16.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Scienture Holdings, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 542,353 to 79,072,121, a change of 78,529,768 (14479.5%).
- Net income of 9,065,798 contributed positively to equity growth.
- Dividend payments of 14,858,831 reduced retained earnings.
- Other factors increased equity by 84,322,801.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $9.07 Million | +11.47% |
| Dividends Paid | $14.86 Million | -18.79% |
| Other Changes | $84.32 Million | +106.64% |
| Total Change | $- | 14479.46% |
Book Value vs Market Value Analysis
This analysis compares Scienture Holdings, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | $8.23 | $0.48 | x |
| 2007-12-31 | $-15.76 | $0.48 | x |
| 2008-12-31 | $-40859.57 | $0.48 | x |
| 2013-12-31 | $0.84 | $0.48 | x |
| 2014-12-31 | $2.02 | $0.48 | x |
| 2015-12-31 | $0.77 | $0.48 | x |
| 2016-12-31 | $-3.28 | $0.48 | x |
| 2017-12-31 | $-0.82 | $0.48 | x |
| 2018-12-31 | $2.18 | $0.48 | x |
| 2019-12-31 | $10.47 | $0.48 | x |
| 2020-12-31 | $16.90 | $0.48 | x |
| 2021-12-31 | $6.95 | $0.48 | x |
| 2022-12-31 | $1.35 | $0.48 | x |
| 2023-12-31 | $0.23 | $0.48 | x |
| 2024-12-31 | $21.64 | $0.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Scienture Holdings, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.47%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6634.66%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.33x
- Recent ROE (11.47%) is above the historical average (-421.15%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -90.20% | 0.00% | 0.00x | 1.36x | $-9.69K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-26.33K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-23.70 Million |
| 2013 | -1598.05% | -218.78% | 2.37x | 3.09x | $-2.10 Million |
| 2014 | -301.01% | -134.47% | 1.22x | 1.83x | $-2.08 Million |
| 2015 | -418.39% | -38.36% | 1.44x | 7.59x | $-1.14 Million |
| 2016 | 0.00% | -111.21% | 7.36x | 0.00x | $-2.65 Million |
| 2017 | 0.00% | 9.86% | 4.75x | 0.00x | $320.18K |
| 2018 | 1.07% | 0.24% | 1.72x | 2.64x | $-75.43K |
| 2019 | -6.87% | -3.82% | 1.33x | 1.35x | $-698.45K |
| 2020 | -29.22% | -14.81% | 1.75x | 1.13x | $-3.40 Million |
| 2021 | -141.00% | -53.75% | 1.72x | 1.53x | $-5.69 Million |
| 2022 | -454.98% | -33.87% | 2.76x | 4.86x | $-3.55 Million |
| 2023 | -3290.03% | -1308.34% | 0.11x | 23.11x | $-17.90 Million |
| 2024 | 11.47% | 6634.66% | 0.00x | 1.33x | $1.16 Million |
Industry Comparison
This section compares Scienture Holdings, Inc.'s net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | $82.67 Million | -90.20% | 0.27x | $16.12 Million |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |